April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Detection of Stem Cell Marker Expression in Uveal Melanoma
Author Affiliations & Notes
  • M. Thill
    Ophthalmology,
    University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • R. Grierson
    Ophthalmology,
    University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • I. Reinhart
    Ophthalmology,
    University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • M. J. Berna
    Internal Medicine,
    University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • G. Richard
    Ophthalmology,
    University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • M. J. Jager
    Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
  • R. Simon
    Pathology,
    University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • U. M. Gehling
    Hepatobiliary Surgery,
    University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Footnotes
    Commercial Relationships  M. Thill, None; R. Grierson, None; I. Reinhart, None; M.J. Berna, None; G. Richard, None; M.J. Jager, None; R. Simon, None; U.M. Gehling, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3377. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Thill, R. Grierson, I. Reinhart, M. J. Berna, G. Richard, M. J. Jager, R. Simon, U. M. Gehling; Detection of Stem Cell Marker Expression in Uveal Melanoma. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3377.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : According to the 'stem cell origin of cancer' hypothesis, tissue-resident stem cells could give rise to cancer. Tumors would then be composed ot different populations: a rare population of "cancer stem cells (CSCs)" and more differentiated tumor cells. This study investigates expression and distribution of stem cell markers in uveal melanoma.

Methods: : A total of 8 cell lines established from primary and metastatic uveal melanomas were cultured and subjected to flow cytometric (FACS) and PCR analysis of hematopoietic and stem cell markers, such as CD133, CD34, c-kit, nestin, bcrp-1, CXCR-4, CD44, VEGFR-2, Pax6, Musashi-1, and Sox-2. In addition, 8 paraffin-embedded uveal melanoma specimens were analyzed by immunohistochemistry (IHC) and immunofluorescence (IF) for CD133, Pax6, Musashi-1, nestin, and Sox2 expression.

Results: : As revealed by FACS analysis, all cell lines were positive for nestin, CD44 and c-kit. Only one cell line also exhibited a small population of CD133-positive cells. Using PCR analysis, different c- and n-terminal isoforms of CD133 were found to be expressed in all the cell lines. Transcripts for nestin, Sox2 and Musashi-1 was also found to be present in all cell lines. IHC and IF unveiled expression of the mentioned stem cell markers by single cells diffusely distributed throughout uveal melanoma.

Keywords: melanoma • immunohistochemistry • gene/expression 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×